KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8+ T-cell-dependent antitumor immunity.
Wu Q, Liu Z, Gao Z, Luo Y, Li F, Yang C, Wang T, Meng X, Chen H, Li J, Kong Y, Dong C, Sun S, Chen C.
Wu Q, et al.
Theranostics. 2023 Feb 21;13(4):1381-1400. doi: 10.7150/thno.82182. eCollection 2023.
Theranostics. 2023.
PMID: 36923542
Free PMC article.